Welcome to the 2017 Academic Annual Report

Jeff Sperring MDBruder Stapleton MDOur founders had a clear vision for Seattle Children’s Hospital when we opened our doors in 1907: to be there for every child in our region who needed care, regardless of race, religion or their family’s ability to pay.

Their bold vision formed the foundation of the mission that has enabled us to thrive for more than a century.

Today we stand poised to address the needs of a new era in healthcare – an era defined by research to develop new cures; translational science to provide pioneering treatments for previously intractable illnesses; and population-based care to keep communities healthier.

Our aim is to bring together the best of our research and clinical care to create a “generation of cure.”

We are on the cusp of incredible advances in neurosciences that will bring more precise, less invasive treatments for children with brain disorders like epilepsy and pediatric stroke. We continue to broaden our immunotherapy research for cancer and diseases of the immune system. We are also pursuing the remarkable potential of gene and cell therapies that could result in one-time cures for genetic disorders like diabetes and sickle cell disease.

In 2017, Seattle Children’s:

  • Was designated one of the nation’s top children’s hospitals by U.S. News & World Report for the 25th consecutive year
  • Received more than $123 million in extramural funding for our research efforts, including $62.2 million from the National Institutes of Health (NIH), $35.2 million from corporations and $25.3 million from philanthropy
  • Ranked #5 among pediatric academic medical institutions in terms of NIH funding
  • Broke ground on Building Cure, a 540,000-square-foot facility that will double our research space to nearly 1 million square feet when it opens in 2019
  • Kicked off It Starts With Yes: The Campaign for Seattle Children’s. This fundraising campaign has a bold goal ($1 billion bold) and an inspiring purpose – to transform the way we approach childhood health and wellness.
  • Launched the Center for Pediatric Nursing Research to advance clinical practice–focused research conducted by nursing staff at all career levels

Some of the 2017 faculty highlights include:

  • Dr. Rita Mangione-Smith receiving the Academic Pediatric Association Research Award recognizing the highest level of research excellence and achievement in the field of general pediatrics at the 2017 meeting in San Francisco
  • Drs. Christy McKinney and Michael Cunningham being honored as 2017 Inventors of the Year by the University of Washington for developing the NIFTY Cup (in collaboration with PATH). The NIFTY Cup is a low-tech, low-cost feeding device that addresses life-threatening malnutrition for babies in low-resource settings who cannot breastfeed.
  • Dr. Dimitri Christakis becoming editor-in-chief of JAMA Pediatrics, replacing Dr. Fred Rivara, who stepped down after 17 years in that role to become the founding editor-in-chief of JAMA Network Open, an international, peer-reviewed, open-access, general medical journal that will publish research and commentary on issues across all health disciplines and countries
  • Dr. Lisa Frenkel being elected as an American Association for the Advancement of Science (AAAS) Fellow

We also welcomed several outstanding faculty and researchers to Seattle Children’s in 2017, including Dr. Mark Wainwright, the new co-director of Seattle Children’s Neurosciences Center, and Dr. Vishal Nigam, a cardiologist whose research focuses on bringing new therapies for hypoplastic left heart syndrome from the bench to the bedside.

We look to the future, inspired by the opportunities ahead. We hope you enjoy reading about some of our research and clinical highlights of the past year.

Warm regards,

Jeff Sperring, MD
Chief Executive Officer, Seattle Children’s

F. Bruder Stapleton, MD
Chief Academic Officer, Seattle Children’s